Home Companies Bayer S.A.

Bayer S.A.

Apartado Aéreo 80387, Av. de las Américas
Bogotá
Colombia

bayerandina.com

Contact

About Bayer

Science For A Better Life / Science for a Better Life is the promise we make to society to create innovations that contribute to solve major challenges of our era: better health, more food and greater well-being.

Read more about Bayer

Advertisement

Revolutionize your production: real-time Raman analysis for maximum efficiency

Revolutionize your production: real-time Raman analysis for maximum efficiency

Efficient inline analysis for liquids and solids

Efficient inline analysis for liquids and solids

User-friendly software for effortless Design of Experiments (DoE)

User-friendly software for effortless Design of Experiments (DoE)

Product portfolio of Bayer

Product portfolio

Show all

News about Bayer

18-Sep-2025 | research and development

Berlin is set to become a hotspot for the development of innovative therapies

More than just a ground-breaking ceremony: start of construction for the Berlin Center for Gene and Cell Therapies

07-Aug-2025 | business & finance

Bayer posts positive second quarter and progress on strategic priorities

The Bayer Group is on track following an encouraging first half of the year. “We’re beginning an important second half of 2025, which will be marked by ...

18-Jul-2025 | people

Supervisory Board of Bayer AG extends contract of CEO Bill Anderson

Far-reaching transformation advancing, delivering first signs of success

25-Jun-2025 | research and development

Bayer extends partnership with Tsinghua University to accelerate pharmaceutical research in China

Extended collaboration underscores Bayer's commitment and growth strategy in innovation in China and globally

14-May-2025 | business & finance

Bayer confirms 2025 targets after solid start to the year

Five-year plan for Crop Science to strengthen the company

28-Apr-2025 | business & finance

“We’re working at full force to put Bayer back on a profitable growth path”

Progress on strategic priorities

06-Mar-2025 | business & finance

Bayer meets adjusted guidance and takes decisive action to tackle challenges

2025 to be a pivotal year for company’s turnaround – improved performance expected from 2026 onwards

20-Feb-2025 | research and development

“Multi Organ Model” - Animal-free alternative for pharmacokinetics research

Dynamic42 and research partners present three-organ system to reduce animal testing

Show more news about Bayer

Here you will find Bayer S.A.

© 1997-2025 LUMITOS AG, All rights reserved